Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clarithromycin for Hypersomnia
NCT01146600Phase 2Completed
- Start
- Jul 2010
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of clarithromycin in central hypersomnia, idiopathic hypersomnia (IH) and narcolepsy (2 arms). Primary endpoint: Psychomotor Vigilance Task Reaction Time at 2 weeks. Started Jul 2010; status: completed.
02
Drugs
clarithromycin
03
Conditions
central hypersomniaidiopathic hypersomnia (IH)narcolepsy
Beyond the preview
Go deeper on NCT01146600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01146600.